Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06136351
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-09-25
Brief Title:
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in Elderly or TP53 Alterations or Chemotherapy Intolerance Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma Mantle-Cell |
Keywords: